Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
23 April 2024
m 16:57 | Head and neck cancer diffhist +3 Jwarner talk contribs →Regimen variant #3, 30 mg/m2 weekly dosing {{#subobject:71731a|Variant=1}} |
m 12:44 | Non-small cell lung cancer, nonsquamous diffhist +1,934 Jwarner talk contribs →Carboplatin, Pemetrexed, Atezolizumab {{#subobject:a4hzv7|Regimen=1}} |
22 April 2024
m 23:37 | Small cell lung cancer diffhist +7 Jwarner talk contribs →Preceding treatment |
|
m 23:16 | Non-small cell lung cancer 3 changes history -13 [Jwarner (3×)] | |||
m |
|
23:16 (cur | prev) -1 Jwarner talk contribs →Radiotherapy | |||
m |
|
23:15 (cur | prev) -25 Jwarner talk contribs →Subsequent treatment | |||
m |
|
23:14 (cur | prev) +13 Jwarner talk contribs →Subsequent treatment |
21 April 2024
m 16:42 | Esophageal cancer diffhist +7 Jwarner talk contribs →Subsequent treatment |
m 16:38 | Classical Hodgkin lymphoma diffhist +96 Jwarner talk contribs |
|
m 16:34 | Breast cancer 2 changes history +14 [Jwarner (2×)] | |||
m |
|
16:34 (cur | prev) +7 Jwarner talk contribs →Subsequent treatment | |||
m |
|
16:33 (cur | prev) +7 Jwarner talk contribs →Subsequent treatment |
20 April 2024
|
m 20:15 | Non-small cell lung cancer 2 changes history +2,451 [Jwarner (2×)] | |||
m |
|
20:15 (cur | prev) +2,200 Jwarner talk contribs →Carboplatin & Docetaxel {{#subobject:bdce59|Regimen=1}} | |||
m |
|
00:17 (cur | prev) +251 Jwarner talk contribs |
|
m 12:56 | Esophageal cancer 2 changes history +112 [Jwarner (2×)] | |||
m |
|
12:56 (cur | prev) +44 Jwarner talk contribs →References | |||
m |
|
12:54 (cur | prev) +68 Jwarner talk contribs |
m 00:40 | Cutaneous squamous cell carcinoma diffhist -140 Jwarner talk contribs |
|
m 00:39 | Classical Hodgkin lymphoma 2 changes history +914 [Jwarner (2×)] | |||
m |
|
00:39 (cur | prev) +69 Jwarner talk contribs | |||
m |
|
00:37 (cur | prev) +845 Jwarner talk contribs |
m 00:22 | Head and neck cancer diffhist +35 Jwarner talk contribs |
m 00:20 | Colorectal cancer diffhist +186 Jwarner talk contribs |
19 April 2024
m 23:55 | Urothelial carcinoma diffhist 0 Jwarner talk contribs |
|
m 23:50 | Melanoma 2 changes history +6 [Jwarner (2×)] | |||
m |
|
23:50 (cur | prev) +3 Jwarner talk contribs →Regimen variant #1, 2 mg/kg q3wk {{#subobject:25a9fe|Variant=1}} | |||
m |
|
23:49 (cur | prev) +3 Jwarner talk contribs →Regimen variant #2, indefinite {{#subobject:722e51|Variant=1}} |
|
m 12:32 | Head and neck cancer 3 changes history +1,820 [Jwarner (3×)] | |||
m |
|
12:32 (cur | prev) +594 Jwarner talk contribs →Methotrexate monotherapy {{#subobject:0e90b2|Regimen=1}} | |||
m |
|
12:25 (cur | prev) +293 Jwarner talk contribs →Cetuximab monotherapy {{#subobject:4b973b|Regimen=1}} | |||
m |
|
12:24 (cur | prev) +933 Jwarner talk contribs →Docetaxel monotherapy {{#subobject:623c3f|Regimen=1}} |
|
m 11:12 | Breast cancer, triple negative 2 changes history -5 [Jwarner (2×)] | |||
m |
|
11:12 (cur | prev) -4 Jwarner talk contribs | |||
m |
|
11:11 (cur | prev) -1 Jwarner talk contribs →Paclitaxel & Pembrolizumab {{#subobject:2g8gua|Regimen=1}} |
|
m 11:00 | Colorectal cancer, MSI-H or dMMR 3 changes history -55 [Jwarner (3×)] | |||
m |
|
11:00 (cur | prev) +8 Jwarner talk contribs →Regimen {{#subobject:3af038|Variant=1}} | |||
m |
|
11:00 (cur | prev) +2 Jwarner talk contribs →Regimen {{#subobject:3af038|Variant=1}} | |||
m |
|
10:59 (cur | prev) -65 Jwarner talk contribs →Pembrolizumab monotherapy {{#subobject:5aa59d|Regimen=1}} |
|
m 00:36 | Esophageal squamous cell carcinoma 3 changes history +27 [Jwarner (3×)] | |||
m |
|
00:36 (cur | prev) -1 Jwarner talk contribs →Nivolumab monotherapy {{#subobject:10ee99|Regimen=1}} | |||
m |
|
00:35 (cur | prev) -1 Jwarner talk contribs →Regimen {{#subobject:d1dde0|Variant=1}} | |||
m |
|
00:35 (cur | prev) +29 Jwarner talk contribs →Camrelizumab monotherapy {{#subobject:c701c3|Regimen=1}} |
m 00:29 | Non-small cell lung cancer, nonsquamous diffhist -39 Jwarner talk contribs →Regimen variant #2, 5/500 x 4, then maintenance pem x 2y {{#subobject:1mwjm3|Variant=1}} |